-
Italian Perspective on Rare Disease New Treatments and HTA: Insights From Iptacopan Multidimensional Evaluation in PNH
Sep 9, 2025, 16:22 PM -
Natural Language Processing for Identification of Negative Symptoms in Patients With and Without Cognitive Impairment Associated With Schizophrenia (CIAS)
Sep 9, 2025, 16:22 PM -
Country-Specific Adaptation of Health Economic Models With Generative AI: A Case Study in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Trends in the Number of Hospital Beds and Patient Turnover in Obstetrics and Gynecology in Hungary Between 2003 and 2023
Sep 9, 2025, 16:22 PM -
Cost Trends for Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Management in Relapsed/Refractory Large B-cell Lymphoma (R/R LBCL) Treatment With Axicabtagene Ciloleucel (Axi-cel) in the US
Sep 9, 2025, 16:22 PM -
Optimizing Patient-Reported Outcomes in German HTA: Addressing Key Challenges and Methodological Requirements
Sep 9, 2025, 16:22 PM -
Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System
Sep 9, 2025, 16:22 PM -
Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review
Sep 9, 2025, 16:22 PM -
Evaluating Clinical Similarity: A Systematic Review of Methods Used Within National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) When Relying on Statistically Nonsignificant Differences From Indirect Treatment...
Sep 9, 2025, 16:22 PM -
Incentivizing Access to New Drugs in Psychiatry: Exploration of a Subscription Payment Approach to Overcome Barriers to European Launch
Sep 9, 2025, 16:22 PM -
Economic Impact of Emicizumab vs. On-Demand Therapy With Bypassing Agents in Patients With Hemophilia A With Inhibitors in Mexico
Sep 9, 2025, 16:22 PM -
Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey
Sep 9, 2025, 16:22 PM -
HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?
Sep 9, 2025, 16:22 PM -
Who Speaks For Europe? A Country-Level Analysis Of Representation And Expertise In EU Health Technology Assessment Joint Bodies
Sep 9, 2025, 16:22 PM -
Hospital Mortality in Germany Analysis of German Hospital Data From 2000 to 2019
Sep 9, 2025, 16:22 PM -
All-Cause Healthcare Resource Use in Recurrent Respiratory Papillomatosis: A Claims-Based Comparison With Matched Controls
Sep 9, 2025, 16:22 PM -
Patient Blood Management With Intravenous Iron Is Economically Advantageous Compared to Usual Care in German Hospitals
Sep 9, 2025, 16:22 PM -
From Promise to Practice: Addressing the Systemic Challenges of Underinvestment in Prevention
Sep 9, 2025, 16:22 PM -
Impact of Disease Progression on Healthcare Resource Utilization and Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
Reducing the Rare Disease Diagnostic Odyssey: Identifying Potential Pulmonary Arterial Hypertension Patients Using the Problem List of Diagnosed Patients
Sep 9, 2025, 16:22 PM
